Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Dexamethasone Emergency use authorization Used to treat other disease Other treatment Jan/21/2022 16 1
Remdesivir Approved by FDA Experimental Antiviral Jan/21/2022 71 5
Convalescent plasma Emergency use authorization Experimental Antiviral Jan/04/2022 40 10
Methylprednisolone Potential treatment - clinical evidence Used to treat other disease Other treatment Nov/03/2021 40 4
Ritonavir Emergency use authorization Used to treat other disease Antiviral Nov/02/2021 27 14
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Jul/12/2021 92 22
Acetylsalicylic acid Potential treatment - clinical evidence Used to treat other disease Other treatment May/23/2021 6 0
Interferon alfa Recommended by China's NHC Guidelines Used to treat other disease Antiviral May/12/2021 6 1
Chloroquine phosphate Recommended by China's NHC Guidelines Used to treat other disease Antiviral Apr/27/2021 25 9
Hydroxychloroquine sulfate Potential treatment - clinical evidence Used to treat other disease Antiviral Apr/27/2021 38 47